Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 12 | Showing Results 1 - 5 of 56

Prospective analysis of brain tumor patient symptoms following air-flight

This study aims to describe the symptoms reported by patients with a brain tumor who travel by air prior to neurological evaluation.

Garni Barkhoudarian, M.D.
  • Providence Los Angeles Research Center
  • Providence St. Johns Health Center (PSJHC)

Phase 1, Multicenter, Open-Label, Dose-Escalation, Combination Study of Marizomib and Bevacizumab in Bevacizumab-Naive Subjects with WHO Grade IV Malignant Glioma

This is a Phase 1/2 clinical trial to evaluate a new combination of drugs, marizomib (MRZ) and bevacizumab (BEV; Avastin), for the treatment of WHO...

Santosh Kesari, M.D.
  • Providence Los Angeles Research Center
  • Providence St. Johns Health Center (PSJHC)

DFC AMG 20110203 GALACTIC-HF-A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects With Chronic Heart Failure With Reduced Ejection Fraction (GALACTIC-HF)

Key Inclusion Criteria: •Male or female, ≥ 18 to ≤ 85 years •History of chronic HF (defined as requiring treatment for HF for a minimum of 30 days...

Daniel Eisenberg, M.D.
  • PMI Cardiology
  • Providence Los Angeles Research Center

TheraSphere HUD-A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma and/or Liver Metastases.

Inclusion Criteria: • Patients diagnosed with hepatocellular carcinoma of the liver and/or liver metastases • Able to provide informed consent •...

Rex Hoffman, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center

Phase 2, Parallel-Arm Study of MGCD265 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Activating Genetic Alterations in Mesenchymal-Epithelial Transition Factor

Inclusion Criteria: •Diagnosis of non-small cell lung cancer •Metastatic or locally advanced disease •Prior platinum chemotherapy or...

Raul Mena, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center
« Previous 12345 Next »
Viewing Page 1 of 12 | Showing Results 1 - 5 of 56